Form 8-K - Current report:
SEC Accession No. 0001193125-22-032077
Filing Date
2022-02-09
Accepted
2022-02-09 10:25:00
Documents
5
Period of Report
2022-02-08
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d303972d8k.htm 8-K 20486
2 EX-3.1 d303972dex31.htm EX-3.1 27205
3 EX-3.2 d303972dex32.htm EX-3.2 159364
4 EX-99.1 d303972dex991.htm EX-99.1 5853
5 GRAPHIC g303972g0209030450034.jpg GRAPHIC 3750
  Complete submission text file 0001193125-22-032077.txt   219465
Mailing Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878
Business Address 25 WEST WATKINS MILL ROAD SUITE A GAITHERSBURG MD 20878 240-723-6641
Arcellx, Inc. (Filer) CIK: 0001786205 (see all company filings)

EIN.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41259 | Film No.: 22604862
SIC: 2836 Biological Products, (No Diagnostic Substances)